Your browser doesn't support javascript.
loading
Radiofrequency Ablation for Liver Cancer.
Radiol Technol ; 86(6): 645-64; quiz 665-8, 2015.
Article in En | MEDLINE | ID: mdl-26199436
Interventional ablative technologies aided by imaging techniques such as ultrasonography, computed tomography, and magnetic resonance imaging have been crucial in managing patients with primary liver cancer and liver metastases over the past 20 years. Several ablative technologies have been used to treat liver cancer; however, radiofrequency ablation (RFA) has emerged as the most common ablative therapy for hepatic lesions, both in the United States and globally. RFA is the treatment of choice for patients who cannot have surgical resection of the liver. This article focuses on the role of imaging in RFA treatment of primary and metastatic hepatic lesions.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Catheter Ablation / Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Radiol Technol Year: 2015 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Catheter Ablation / Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Radiol Technol Year: 2015 Document type: Article